Cargando…
Glycogen synthase kinase-3β inhibitor ameliorates imbalance of connexin 43 in an acute kidney injury model
This study was designed to evaluate whether glycogen synthase kinase-3β (GSK-3β) inhibitor, 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) induced the the expression of connexin 43 (Cx43) to protect against renal ischemia–reperfusion (I/R) injury (RI/RI) in rats. Rats were subjected to 4...
Autores principales: | Wang, Yini, Tong, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598357/ https://www.ncbi.nlm.nih.gov/pubmed/28962480 http://dx.doi.org/10.1016/j.toxrep.2015.10.005 |
Ejemplares similares
-
Inhibition of glycogen synthase kinase 3β prevents NSAID-induced acute kidney injury
por: Bao, Hao, et al.
Publicado: (2012) -
Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors
por: Hulcová, Daniela, et al.
Publicado: (2018) -
Pharmacologically Inhibiting Glycogen Synthase Kinase-3β Ameliorates Renal Inflammation and Nephrotoxicity in an Animal Model of Cisplatin-Induced Acute Kidney Injury
por: Hsing, Chung-Hsi, et al.
Publicado: (2021) -
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2017) -
Glycogen synthase kinase-3β inhibitor reduces LPS-induced acute lung injury in mice
por: Ding, Qi, et al.
Publicado: (2017)